Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors

Clinical trial NCT05075993 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05075993
Sponsor: M.D. Anderson Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Esophageal Gastric Cancer Metastatic Head and Neck Carcinoma Metastatic Hepatocellular Carcinoma Metastatic HPV Related Solid Tumors Metastatic Ovarian Carcinoma Metastatic Soft Tissue Sarcoma Metastatic Uveal Melanoma

Start date: 2021-11-12
Primary completion: 2027-02-02
Enrollment: 352

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.